Nuclear medicine imaging of the pediatric musculoskeletal system

Seminars in Musculoskeletal Radiology

Volumn 13, Issue 3, 2009, Pages 159-180

  Shammas, Amer ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone; Children; FDG; Musculoskeletal; PET CT; Scintigraphy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ACUTE DISEASE; ARTICLE; BACTERIAL ARTHRITIS; BENIGN TUMOR; BONE SCINTISCANNING; CHILDHOOD CANCER; CHILDHOOD DISEASE; CHRONIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; EWING SARCOMA; HUMAN; INJURY; LEUKEMIA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL SYSTEM; NEUROBLASTOMA; NUCLEAR MEDICINE; OSTEOMYELITIS; OSTEOSARCOMA; PEDIATRICS; PERTHES DISEASE; POSITRON EMISSION TOMOGRAPHY; SICKLE CELL ANEMIA; SOFT TISSUE SARCOMA; SYNOVITIS;

BONE AND BONES; CHILD; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MUSCULOSKELETAL DISEASES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 70350491314     PISSN: 10897860     EISSN: 1098898X     Source Type: Journal    
DOI: 10.1055/s-0029-1237687     Document Type: Article

References (82)

1. Connolly L P., Drubach S A., Connolly S A., Treves S T. Bone In: Treves ST Pediatric Nuclear Medicine/PET. 3rd ed. New York, NY Springer 2007 312-403
2. Nadel H R., Stilwell M E. Nuclear medicine topics in pediatric musculoskeletal disease: techniques and applications. Radiol Clin North Am 2001 39 (4) 619-651
3. Gilday D L. Specific problems and musculoskeletal imaging in children In: Sandler MP, Coleman RE, Patton JA, et al Diagnostic Nuclear Medicine. 4th ed. Philadelphia, PA Lippincott Williams and Wilkins 2003 1107-1115
4. Connolly L P., Drubach L A., Treves S T. Pediatric skeletal scintigraphy In: Henkin RE, Bova D, Dillehay GL, Karesh SM, Halama JR, Wagner RH Nuclear Medicine. 2nd ed. Philadelphia, PA Mosby-Elsevier 2006 1721-1744
5. Ma J J., Kang B K., Treves S T. Pediatric musculoskeletal nuclear medicine. Semin Musculoskelet Radiol 2007 11 (4) 322-334
6. Nadel H R. Bone scan update. Semin Nucl Med 2007 37 (5) 332-339
7. Bybel B, Brunken R C., DiFilippo F P., Neumann D R., Wu G, Cerqueira M D. SPECT/CT imaging: clinical utility of an emerging technology. Radiographics 2008 28 (4) 1097-1113
8. Horger M, Bares R. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease. Semin Nucl Med 2006 36 (4) 286-294
9. Domingues R C., Carneiro M P., Lopes F C., Domingues R C., da Fonseca L M., Gasparetto E L. Whole-body MRI and FDG PET fused images for evaluation of patients with cancer. AJR Am J Roentgenol 2009 192 (4) 1012-1020
10. Pauwels E K., Ribeiro M J., Stoot J H., McCready V R., Bourguignon M, Mazire B. FDG accumulation and tumor biology. Nucl Med Biol 1998 25 (4) 317-322
11. Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002 32 (1) 47-59
12. Love C, Tomas M B., Tronco G G., Palestro C J. FDG PET of infection and inflammation. Radiographics 2005 25 (5) 1357-1368
13. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992 33 (11) 1972-1980
14. Iagaru A, Mittra E, Yaghoubi S S. et al. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. J Nucl Med 2009 50 (4) 501-505
15. Stauss J, Franzius C, Pfluger T et al, European Association of Nuclear Medicine. Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging 2008 35 (8) 1581-1588
16. Barrington S F., Begent J, Lynch T et al. Guidelines for the use of PET-CT in children. Nucl Med Commun 2008 29 (5) 418-424
17. Delbeke D, Coleman R E., Guiberteau M J. et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med 2006 47 (5) 885-895
18. Brix G, Lechel U, Glatting G et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med 2005 46 (4) 608-613
19. Fahey F H., Palmer M R., Strauss K J., Zimmerman R E., Badawi R D., Treves S T. Dosimetry and adequacy of CT-based attenuation correction for pediatric PET: phantom study. Radiology 2007 243 (1) 96-104
20. Jadvar H, Connolly L P., Fahey F H., Shulkin B L. PET and PET/CT in pediatric oncology. Semin Nucl Med 2007 37 (5) 316-331
21. Cook G J., Wegner E A., Fogelman I. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med 2004 34 (2) 122-133
22. Jackson R S., Schlarman T C., Hubble W L., Osman M M. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET. J Nucl Med Technol 2006 34 (1) 29-33
23. Barrington S F., Maisey M N. Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med 1996 37 (7) 1127-1129
24. Yeung H W., Grewal R K., Gonen M, Schöder H, Larson S M. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 2003 44 (11) 1789-1796
25. Gelfand M J., O'Hara S M., Curtwright L A., Maclean J R. Pre-medication to block [(18)F]FDG uptake in the brown adipose tissue of pediatric and adolescent patients. Pediatr Radiol 2005 35 (10) 984-990
26. Parysow O, Mollerach A M., Jager V, Racioppi S, San Roman J, Gerbaudo V H. Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin Nucl Med 2007 32 (5) 351-357
27. Kazama T, Swanston N, Podoloff D A., Macapinlac H A. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging 2005 32 (12) 1406-1411
28. Faden H, Grossi M. Acute osteomyelitis in children. Reassessment of etiologic agents and their clinical characteristics. Am J Dis Child 1991 145 (1) 65-69
29. Connolly L P., Treves S T. Assessing the limping child with skeletal scintigraphy. J Nucl Med 1998 39 (6) 1056-1061
30. Wegener W A., Alavi A. Diagnostic imaging of musculoskeletal infection. Roentgenography; gallium, indium-labeled white blood cell, gammaglobulin, bone scintigraphy; and MRI. Orthop Clin North Am 1991 22 (3) 401-418
31. Schauwecker D S. The scintigraphic diagnosis of osteomyelitis. AJR Am J Roentgenol 1992 158 (1) 9-18
32. Traughber P D., Manaster B J., Murphy K, Alazraki N P. Negative bone scans of joints after aspiration or arthrography: experimental studies. AJR Am J Roentgenol 1986 146 (1) 87-91
33. Pennington W T., Mott M P., Thometz J G., Sty J R., Metz D. Photopenic bone scan osteomyelitis: a clinical perspective. J Pediatr Orthop 1999 19 (6) 695-698
34. Tsao A K., Dias L S., Conway J J., Straka P. The prognostic value and significance of serial bone scintigraphy in Legg-Calv-Perthes disease. J Pediatr Orthop 1997 17 (2) 230-239
35. Conway J J. A scintigraphic classification of Legg-Calv-Perthes disease. Semin Nucl Med 1993 23 (4) 274-295
36. Comte F, De Rosa V, Zekri H et al. Confirmation of the early prognostic value of bone scanning and pinhole imaging of the hip in Legg-Calv-Perthes disease. J Nucl Med 2003 44 (11) 1761-1766
37. Skaggs D L., Kim S K., Greene N W., Harris D, Miller J H. Differentiation between bone infarction and acute osteomyelitis in children with sickle-cell disease with use of sequential radionuclide bone-marrow and bone scans. J Bone Joint Surg Am 2001 83-A (12) 1810-1813
38. Drubach L A., Connolly L P., D'Hemecourt P A., Treves S T. Assessment of the clinical significance of asymptomatic lower extremity uptake abnormality in young athletes. J Nucl Med 2001 42 (2) 209-212
39. Zwas S T., Elkanovitch R, Frank G. Interpretation and classification of bone scintigraphic findings in stress fractures. J Nucl Med 1987 28 (4) 452-457
40. Anderson M W., Greenspan A. Stress fractures. Radiology 1996 199 (1) 1-12
41. Ishibashi Y, Okamura Y, Otsuka H, Nishizawa K, Sasaki T, Toh S. Comparison of scintigraphy and magnetic resonance imaging for stress injuries of bone. Clin J Sport Med 2002 12 (2) 79-84
42. Sty J R., Wells R G., Conway J J. Spine pain in children. Semin Nucl Med 1993 23 (4) 296-320
43. Connolly L P., d'Hemecourt P A., Connolly S A., Drubach L A., Micheli L J., Treves S T. Skeletal scintigraphy of young patients with low-back pain and a lumbosacral transitional vertebra. J Nucl Med 2003 44 (6) 909-914
44. Bron J L., van Royen B J., Wuisman P I. The clinical significance of lumbosacral transitional anomalies. Acta Orthop Belg 2007 73 (6) 687-695
45. Pekindil G, Sarikaya A, Pekindil Y, Gültekin A, Kokino S. Lumbosacral transitional vertebral articulation: evaluation by planar and SPECT bone scintigraphy. Nucl Med Commun 2004 25 (1) 29-37
46. Mandelstam S A., Cook D, Fitzgerald M, Ditchfield M R. Complementary use of radiological skeletal survey and bone scintigraphy in detection of bony injuries in suspected child abuse. Arch Dis Child 2003 88 (5) 387-390 discussion 387-390
47. Conway J J., Collins M, Tanz R R. et al. The role of bone scintigraphy in detecting child abuse. Semin Nucl Med 1993 23 (4) 321-333
48. Intenzo C M., Kim S M., Capuzzi D M. The role of nuclear medicine in the evaluation of complex regional pain syndrome type I. Clin Nucl Med 2005 30 (6) 400-407
49. Goodin G S., Shulkin B L., Kaufman R A., McCarville M B. PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease. AJR Am J Roentgenol 2006 187 (4) 1124-1128
50. Aoki J, Watanabe H, Shinozaki T et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001 219 (3) 774-777 (Pubitemid 32476270)
51. Schulte M, Brecht-Krauss D, Heymer B et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 2000 41 (10) 1695-1701
52. Tse W L., Hung L K., Law B, Ho P C. Enhanced localization of osteoid osteoma with radiolabeling and intraoperative gamma counter guidance: a case report. J Hand Surg [Am] 2003 28 (4) 699-703
53. Klonecke A S., Licho R, McDougall I R. A technique for intraoperative bone scintigraphy. A report of 17 cases. Clin Nucl Med 1991 16 (7) 482-486
54. Lim C H., Park Y H., Lee S Y., Chung S K. F-18 FDG uptake in the nidus of an osteoid osteoma. Clin Nucl Med 2007 32 (8) 628-630
55. Azouz E M., Saigal G, Rodriguez M M., Podda A. Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement. Pediatr Radiol 2005 35 (2) 103-115
56. Dogan A S., Conway J J., Miller J H., Grier D, Bhattathiry M M., Mitchell C S. Detection of bone lesions in Langerhans cell histiocytosis: complementary roles of scintigraphy and conventional radiography. J Pediatr Hematol Oncol 1996 18 (1) 51-58
57. Kaste S C., Rodriguez-Galindo C, McCarville M E., Shulkin B L. PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Radiol 2007 37 (7) 615-622
58. Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 2009 52 (1) 97-101
59. Zhibin Y, Quanyong L, Libo C et al. The role of radionuclide bone scintigraphy in fibrous dysplasia of bone. Clin Nucl Med 2004 29 (3) 177-180
60. Bonekamp D, Jacene H, Bartelt D, Aygun N. Conversion of FDG PET activity of fibrous dysplasia of the skull late in life mimicking metastatic disease. Clin Nucl Med 2008 33 (12) 909-911
61. Iagaru A, Henderson R. PET/CT follow-up in nonossifying fibroma. AJR Am J Roentgenol 2006 187 (3) 830-832
62. Eary J F., O'Sullivan F, Powitan Y et al. Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. Eur J Nucl Med Mol Imaging 2002 29 (9) 1149-1154
63. Brenner W, Bohuslavizki K H., Eary J F. PET imaging of osteosarcoma. J Nucl Med 2003 44 (6) 930-942
64. Franzius C, Daldrup-Link H E., Sciuk J et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001 12 (4) 479-486
65. Costelloe C M., Macapinlac H A., Madewell J E. et al. 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med 2009 50 (3) 340-347
66. Nair N. Bone scanning in Ewing's sarcoma. J Nucl Med 1985 26 (4) 349-352
67. Ozcan Z, Burak Z, Kumanliolu K et al. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy. Nucl Med Commun 1999 20 (1) 41-48
68. Kleis M, Daldrup-Link H, Matthay K et al. Diagnostic value of PET/CT for the staging and restaging of pediatric tumors. Eur J Nucl Med Mol Imaging 2009 36 (1) 23-36
69. Franzius C, Sciuk J, Daldrup-Link H E., Jürgens H, Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 2000 27 (9) 1305-1311
70. Hawkins D S., Rajendran J G., Conrad E U. III, Bruckner J D., Eary J F. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer 2002 94 (12) 3277-3284
71. Arush M W., Israel O, Postovsky S et al. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Pediatr Blood Cancer 2007 49 (7) 901-905
72. Gerth H U., Juergens K U., Dirksen U, Gerss J, Schober O, Franzius C. Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors. J Nucl Med 2007 48 (12) 1932-1939
73. Kushner B H. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med 2004 45 (7) 1172-1188
74. Shulkin B L., Wieland D M., Baro M E. et al. PET hydroxyephedrine imaging of neuroblastoma. J Nucl Med 1996 37 (1) 16-21
75. Tzen K Y., Wang LY, Lu My. Characterization of neuroblastic tumors using F-18-DOPA PET [abstract]. J Nucl Med 2007 48 (suppl 2) 117P
76. Mulligan M E., McRae G A., Murphey M D. Imaging features of primary lymphoma of bone. AJR Am J Roentgenol 1999 173 (6) 1691-1697
77. Bernard E J., Nicholls W D., Howman-Giles R B., Kellie S J., Uren R F. Patterns of abnormality on bone scans in acute childhood leukemia. J Nucl Med 1998 39 (11) 1983-1986
78. Shalaby-Rana E, Majd M. (99m)Tc-MDP scintigraphic findings in children with leukemia: value of early and delayed whole-body imaging. J Nucl Med 2001 42 (6) 878-883
79. Hickeson M P. Soft tissue sarcomas In: Charron M Practical Pediatric PET Imaging. New York, NY Springer 2006 302-311
80. Klem M L., Grewal R K., Wexler L H., Schöder H, Meyers P A., Wolden S L. PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging tools. J Pediatr Hematol Oncol 2007 29 (1) 9-14
81. McCarville M B., Christie R, Daw N C., Spunt S L., Kaste S C. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol 2005 184 (4) 1293-1304
82. Tateishi U, Hosono A, Makimoto A et al. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med 2009 23 (2) 155-161